Getting to know GH&B

• Global Hospital & Biosimilars (GH&B) makes the products that are the foundation of hospital care – sterile injectables and biosimilars – that reach more than 100 million patients annually, generating $5 billion in revenue for Pfizer. These are not niche products; they are for when patients are at the most vulnerable, essential to access and acute care delivery worldwide.
• GH&B is Pfizer's only truly end-to-end business, spanning from our 12 global manufacturing sites through to commercial in a single integrated organization. It was created to give this portfolio dedicated focus, clearer accountability, and a fit-for-purpose operating model – recognizing that GH&B's portfolio has different economics, customer dynamics, and execution needs than Pfizer's innovative business.
• By bringing Commercial and Supply into one organization, GH&B enables faster decision-making, stronger prioritization, and expanded capabilities for this important portfolio.
• Our ambition: Rebuild a healthy operation positioned to serve patients for generations to come

Use Your Power for Purpose

• The Market Access & Pricing Lead defines and governs the pricing and market access strategy for the full GH&B portfolio – both hospital sterile injectables and biosimilars - across international markets. The role sets the frameworks, corridors, and escalation governance within which eight clusters make pricing, reimbursement, and formulary decisions, ensuring that individual market actions are commercially sound and globally coherent.
• This is a high-impact strategy and governance role in a portfolio where pricing is the primary competitive lever. The Market Access & Pricing Lead protects and optimizes portfolio value by equipping local teams with analytical frameworks, policy guardrails, and strategic guidance to make better pricing decisions faster - balancing speed with discipline across tender-driven, margin-sensitive markets, without owning execution directly.

What You Will Achieve

Pricing Strategy & Governance

• Define the international pricing framework for the GH&B portfolio including pricing corridors, floor/ceiling thresholds, reference pricing principles, and market-type archetypes (tender-driven, free-pricing, reference-pricing-sensitive) that enable clusters to move fast within guardrails
• Own pricing governance: set decision rights, escalation criteria, and approval thresholds for market-level pricing actions with material P&L impact; exercise commercial judgment on time-sensitive escalations where speed and accuracy both matter
• Lead pricing strategy for high-stakes moments e.g., new product launches (entry positioning, corridor setting, cross-market sequencing), competitive responses, and tender rebids - defining the parameters within which clusters act
• Ensure pricing compliance across markets through structured oversight and exception management, identifying cross-border reference pricing risks and recommending corrective actions

Market Access Strategy & Payor Engagement

• Set the above-market access and reimbursement strategy for the GH&B portfolio, including formulary positioning, HTA engagement principles, and institutional access pathways
• Provide strategic guidance to clusters on market access challenges including reimbursement negotiations, hospital listing strategies, and payor value propositions tailored to portfolio economics (volume-driven, cost-leadership positioning)
• Develop access playbooks and value argumentation frameworks that equip local market teams to navigate payor and institutional decision-makers, ensuring they remain current as competitive and policy dynamics evolve
• Monitor the evolving policy and regulatory landscape (e.g., reference pricing reforms, HTA policy evolution, biosimilar interchangeability regulations) and advise on implications for portfolio access and pricing strategy

Performance Oversight & Analytics

• Define the pricing and access performance agenda determining KPIs and ensuring the commercial performance infrastructure surfaces the right signals to the International Leadership Team
• Partner with the Director of Business Operations / Commercial Performance function to ensure pricing and access analytics are embedded in the commercial performance infrastructure
• Define mitigation scenarios for revenue-at-risk scenarios from pricing and access dynamics in partnership with the Biosimilars and Hospital Portfolio Leads

Above-Market Guidance & Capability Building

• Serve as strategic advisor to Cluster Leads and local Tender, Contracting & Account Management teams on pricing and access decisions – shaping outcomes through credibility, analytical rigor, and commercial logic rather than direct-line authority
• Build pricing and market access as a discipline across the international community developing tools, training, and decision frameworks that raise the quality and consistency of local decision-making
• Enable rapid dissemination of winning approaches across clusters, creating structured channels for peer learning on pricing tactics, access strategies, and competitive responses
• Influence commercial decision-making across clusters by building trust and demonstrating value ensuring that above-market guidance is sought proactively, beyond governance requirements

Cross-Functional Integration & Stakeholder Alignment

• Ensure pricing and access strategy is integrated with portfolio strategy, supply realities, and financial planning
• Define pricing corridors and escalation triggers; Finance approves day-to-day pricing within corridors, this role intervenes on out-of-corridor decisions
• Partner with the Partnerships & Alliances Lead on pricing dimensions of external partnerships, distribution agreements, and alliance structures
• Coordinate with Regulatory and Medical on access-related submissions, clinical evidence requirements, and policy advocacy where appropriate
• Align with Pfizer Global Pricing and Market Access functions on enterprise pricing policies, transfer pricing, and cross-BU reference pricing exposure

Technology & AI Enablement

• Define requirements for pricing and access tooling including competitive price monitoring, scenario modeling, and corridor compliance dashboards – in partnership with Commercial Performance and Data & Analytics teams
• Demonstrate strong personal digital literacy and AI fluency, modelling practical use of data, digital tools, and AI-enabled solutions
• Model AI-enabled ways of working within the pricing and access discipline, demonstrating practical application of data tools and AI-enabled solutions
• Champion adoption of AI-enabled pricing analytics (e.g., tender outcome prediction, price elasticity modeling, reference pricing simulation) to accelerate and improve decision quality
• Ensure responsible use of AI in pricing decisions through appropriate governance and human oversight

What you need to achieve this:

• Leading Through Change: Demonstrated experience leading leaders and teams through complex change, including navigating ambiguity, influencing across stakeholders, and sustaining performance during transformation
• End-to-End Process Thinking: Proven ability to think and operate end-to-end, connecting strategy to execution across functions and anticipating downstream impacts to deliver integrated, enterprise-level solutions
• Commercial Judgment Under Pressure: Track record of making high-stakes pricing decisions in competitive, margin-sensitive environments where speed and accuracy both matter

Here Is What You Need (Minimum Requirements)

• Bachelor’s degree in business, Economics, Health Economics, Life Sciences, or related field
• 12+ years of progressive experience in pricing, market access, or commercial strategy within pharmaceuticals, biosimilars, or generics
• Deep expertise in international pricing frameworks, reference pricing systems, cross-border pricing risk management, and tender-driven market dynamics
• Proven experience in above-market or regional pricing/access roles with demonstrated influence on portfolio P&L outcomes
• Strong understanding of international reference pricing dynamics and cross-border pricing risk management
• Strong analytical capabilities with ability to model pricing scenarios, assess cross-border implications, and translate complex analytics into clear strategic recommendations
• Experience shaping payor and institutional access strategies across multiple geographies
• Fluency in English required; additional languages an asset

Bonus points if you have (preferred requirements)

• Master’s degree with relevant pharmaceutical industry experience
• Direct experience in biosimilar or generics pricing and market access, including tender strategy and competitive price positioning
• Background in health economics, HTA submissions, or institutional formulary management
• Experience designing pricing governance frameworks and escalation processes for multi-market organizations
• Track record of building pricing/access capabilities across dispersed teams
• Experience working within integrated end-to-end business models (commercial + supply) where cost-to-serve directly shapes pricing strategy
• Proficiency in pricing analytics tools and BI platforms

Other Job details:

Work location: Hybrid

Last date to apply: September 11, 2026

The annual base salary for this position ranges from $214,900.00 to $358,100.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 22.5% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. This role is posted in multiple locations. If you are applying for the role in an secondary job posting location where pay transparency regulations apply, your Talent Advisor will share the local pay information with you during the first interview.

Relocation assistance may be available based on business needs and/or eligibility.

Candidates must be authorized to be employed in the U.S. by any employer.

U.S. work visa sponsorship (such as TN, O-1, H-1B, etc.) is not available for this role now or in the future.

To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers.

Mkt & Sales/Commercial Bus